Potassium Iodide prices in the Asian market went up in the first half of October 2025, following the September uptrend due to higher Iodine feedstock costs and steady demand from pharma and nutraceutical sectors. September’s increase was driven by higher production costs, low inventories and continuous export from China and India. Healthcare demand for thyroid and radiation protection formulations kept offtake robust and iodine supplementation awareness supported the nutraceutical segment. China’s stable production and India’s policy backed production ensured supply was uninterrupted and regional trade was balanced. Logistics improved and export inquiry from North America and Europe was steady, and market was confident. In early October, restocking activity in Asia picked up as buyers replenished their inventory before year end. Market expects Potassium Iodide prices to go up modestly in the second half of October supported by demand and procurement, but ample supply will keep the gains moderate.
Potassium Iodide prices in Asia continued to go up in the first half of October 2025 after September’s increase, driven by rising raw material costs and steady demand from pharma and nutraceutical industries. Importers and manufacturers in China, India and Southeast Asia restocked for year-end production.
September’s Potassium Iodide uptrend was mainly due to global Iodine price surge caused by brine extraction constraint in major producing countries like Chile and Japan. Caustic Potash prices remained firm with stable electrolytic output and higher energy-driven production costs in Asia. Although input costs went up, supply in the region was well balanced with Chinese and Indian Potassium Iodide producers running steady and exporting normally. Stable logistics, improved currency parity and the extension of US-China tariff truce helped smooth trade and lean inventories after August drawdowns kept Potassium Iodide price firm.
In China, Potassium Iodide producers benefited from consistent overseas demand, especially from North America and Europe where pharma companies increased orders for thyroid and radiation related formulations. The country’s stable production base, supported by policy incentives for chemical production, ensured continuous Potassium Iodide output. Rising usage in nutraceuticals driven by iodine supplementation awareness and preventive healthcare trend strengthened domestic consumption. Higher feedstock costs and growing end-use demand allowed Chinese exporters to maintain steady quotes through September and hence the momentum continued into October.
In India, the Potassium Iodide market was similar, prices went up in line with regional trend. Strong procurement from pharma manufacturers, especially those producing thyroid medication and radioprotective treatments, supported the market. Nutraceutical industry also contributed to Potassium Iodide price rise, with clean-label supplement lines expanding consumption. Government support through PLI Scheme ensured stable production and supply continuity, while predictable currency and port logistics sustained export commitments. Better alignment between manufacturers and distributors helped balance inventories, preventing accumulation, and enabling consistent supply to both domestic and global Potassium Iodide buyers.
The Asian Potassium Iodide market was stable up to early October as consumption fundamentals grew and restocking was synchronized. Feedstock prices rose and demand from healthcare and industrial segments increased, providing a solid base for the market to stay firm. Potassium Iodide buyers in Asia took a cautious approach to procurement, stockpiling enough inventory ahead of the peak season.
According to market Analysts, Potassium Iodide prices are expected to go up in 2nd half of October as restocking done earlier and selective procurement continues. Mild demand from downstream will support firm offers and balanced supply will prevent sharp increase. With procurement improving, logistics stable and consumption consistent, the Potassium Iodide market will continue to trend up for the rest of October 2025.
